Treatment for Shoulder Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Shoulder Pain+1 More
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial is designed to see if there is a difference in physician preference when the SurgiQuest AirSeal® Insufflation System is used at a low pressure vs. a high pressure for the management of pneumoperitoneum.

Eligible Conditions
  • Shoulder Pain

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: During procedure

Day 30
Procedural related Adverse Events/ Serious Adverse Events (AEs/ SAEs?
During procedure
Ease of anesthesia management
Pressure stability
Rate of device-related events
Day 10
Pain severity and trend
Hour 24
Length of recovery room stay
Hour 24
Post-operative shoulder pain
Day 10
Length of Stay (LOS)

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

102 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: during procedure

Who is running the clinical trial?

Akron Children's HospitalLead Sponsor
45 Previous Clinical Trials
5,005,266 Total Patients Enrolled
Todd Ponsky, MDPrincipal InvestigatorAkron Children's Hospital

Eligibility Criteria

Age < 65 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are under 21 years of age.
You are over 20 kilograms in weight.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 12th, 2021

Last Reviewed: October 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.